Stathmin‐mediated disruption of microtubule dynamics is a key factor that induces the combined lethality of RB1‐deficient cancers and suggests that upstream factors that regulate microtubule dynamics, such as AURKA could be potential therapeutic targets for RB1‐deficient cancers.20 The gene discussed is STMN1; the disease is cancer.